FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between K2 Infragen IPO and Ramdevbaba Solvent IPO.
K2 Infragen IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Ramdevbaba Solvent IPO is a SME Book Built Issue proposed to list at NSE SME.
K2 Infragen IPO | Ramdevbaba Solvent IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | NSE SME | NSE SME |
Lead Managers | Expert Global Consultants Private Limited | Choice Capital Advisors Pvt Ltd |
Registrar | Kfin Technologies Limited | Bigshare Services Pvt Ltd |
Market Maker | Rikhav Securities Limited | Choice Equity Broking Private Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of K2 Infragen IPO is up to ₹40.54 Cr whereas the issue size of the Ramdevbaba Solvent IPO is up to ₹50.27 Cr. The final issue price of K2 Infragen IPO is ₹119.00 per share and of Ramdevbaba Solvent IPO is ₹85.00 per share.
K2 Infragen IPO | Ramdevbaba Solvent IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹111.00 per share | ₹80.00 per share |
Issue Price (Upper) | ₹119.00 per share | ₹85.00 per share |
Issue Price (Final) | ₹119.00 per share | ₹85.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 1200 shares | 1600 shares |
Fresh Issue Size | 34,06,800 shares | 59,13,600 shares |
Fresh Issue Size (Amount) | up to ₹40.54 Cr | up to ₹50.27 Cr |
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 34,06,800 shares | 59,13,600 shares |
Issue Size Total (Amount) | up to ₹40.54 Cr | up to ₹50.27 Cr |
K2 Infragen IPO opens on Mar 28, 2024, while Ramdevbaba Solvent IPO opens on Apr 15, 2024. The closing date of K2 Infragen IPO and Ramdevbaba Solvent IPO is Apr 03, 2024, and Apr 18, 2024, respectively.
K2 Infragen IPO | Ramdevbaba Solvent IPO | |
---|---|---|
Anchor Bid Date | Mar 27, 2024 | Apr 12, 2024 |
Issue Open | Mar 28, 2024 | Apr 15, 2024 |
Issue Close | Apr 03, 2024 | Apr 18, 2024 |
Basis Of Allotment (Tentative) | Apr 04, 2024 | Apr 19, 2024 |
Initiation of Refunds (Tentative) | Apr 05, 2024 | Apr 22, 2024 |
Credit of Share (Tentative) | Apr 05, 2024 | Apr 22, 2024 |
Listing date (Tentative) | Apr 08, 2024 | Apr 23, 2024 |
Anchor Lockin End date 1 | May 04, 2024 | May 19, 2024 |
Anchor Lockin End date 2 | Jul 03, 2024 | Jul 18, 2024 |
K2 Infragen IPO P/E ratio is 9.68, as compared to Ramdevbaba Solvent IPO P/E ratio of 10.6.
K2 Infragen IPO | Ramdevbaba Solvent IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | K2 Infragen Limited Financial Information (Restated Consolidated)K2 Infragen Limited's revenue increased by 103.25% and profit after tax (PAT) rose by 463.79% between the financial year ending with March 31, 2023 and March 31, 2022.
|
Ramdevbaba Solvent Limited Financial Information (Restated)Ramdevbaba Solvent Limited's revenue increased by 20.35% and profit after tax (PAT) rose by 97.25% between the financial year ending with March 31, 2023 and March 31, 2022.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 55.29% | 81.01% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 40.36% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 9.68 | 10.6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹150.16 Cr. | ₹188.07 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 23.96%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 19.91%% | 10.76%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.87 | 1.46 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹12.29 | ₹8.02 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 23.9%% | 14.24%% |
In the K2 Infragen IPO retail investors (RII) are offered 11,05,200 shares while in Ramdevbaba Solvent IPO retail investors are offered 11,05,200 shares. Qualified institutional buyers (QIB) are offered 6,31,200 shares in K2 Infragen IPO and 11,20,000 shares in Ramdevbaba Solvent IPO.
K2 Infragen IPO | Ramdevbaba Solvent IPO | |
---|---|---|
Anchor Investor Reserveration | 9,46,800 shares | 16,80,000 shares |
Market Maker Reserveration | 2,49,600 shares | 3,13,600 shares |
QIB | 6,31,200 shares | 11,20,000 shares |
NII | 4,74,000 shares | 8,40,000 shares |
RII | 11,05,200 shares | 19,60,000 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 22,10,400 shares | 39,20,000 shares |
K2 Infragen IPO subscribed 51.47x in total, whereas Ramdevbaba Solvent IPO subscribed 126.21x.
K2 Infragen IPO | Ramdevbaba Solvent IPO | |
---|---|---|
QIB (times) | 23.37x | 65.95x |
NII (times) | 113.98x | 314.46x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 40.70x | 79.96x |
Employee (times) | ||
Other (times) | ||
Total (times) | 51.47x | 126.21x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|